SEARCH   
MEMBER LOGIN    

Pharmaceutical Product Manufacturing in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Pharmaceutical Product Manufacturing Market Research Report | ANZSIC C1841 | Mar 2014

Bitter pill: Industry players must adapt as more drugs lose patent protection

IBISWorld’s Pharmaceutical Product Manufacturing market research report can be used to help you: understand market size and growth potential; major companies; draft business plans and pitch books; and conduct benchmarking and SWOT analysis. Our industry analysis highlights macro industry trends in the overall sector and micro trends faced by companies that do business in the industry. The industry report also provides key industry statistics and 5-year forecasts to anticipate future industry prospects so you can decide with confidence.

Report Snapshot
Industry Statistics & Market Size
Revenue
$10bn
Annual Growth 09-14
1.7%
Annual Growth 14-19
Add to Cart
Profit
Add to Cart
Employment
15,275
Businesses
147
Industry Analysis & Industry Trends

The Pharmaceutical Product Manufacturing industry is an important component of the pharmaceutical sector. The major global pharmaceutical groups dominate the local industry, although only a small number are engaged in secondary or actives manufacturing (i.e. active pharmaceutical ingredients). An increasing number are involved in the later stages of the manufacturing process, such as dispensing, packaging and the fill-and-finish stage. A large number of players also restrict their activities in Australia to distribution.

Industry revenue is expected to grow by a meagre 0.8% over 2013-14, as various internal and external factors take their toll. IBISWorld forecasts that the industry will generate revenue of $9.9 billion in 2013-14, up from $9.0 billion in 2008-09... purchase to read more

Industry Report - Starting a New Business Chapter

Substantial barriers to entry to the industry do exist, not least of which is the fact that the industry is becoming increasingly globalised, with major players operating on a large global scale. In Australia, eight of the top 10 companies are subsidiaries of established multinational operators with significant market strengths on both a global and local basis.

The high and rising costs of R&D, combined with declining R&D productivity pose another substantial obstacle. In Australia, the pharmaceutical industry is the second most innovative manufacturing industry. High levels of capital expenditure are also required at the onset to establish a manufacturing plant geared to producing high-cost, high-technology drugs.

Government policies can be significant barriers to entry... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Pharmaceutical Product Manufacturing Industry?

The industry comprises companies that manufacture various medicinal and pharmaceutical products for human use from both synthetic (chemicals) and natural sources. Other products include chemical or diagnostic testing agents, blood serums and biotech products. Industry products are distributed directly by the manufacturer or via wholesalers to hospitals and community pharmacies.

Industry Products
Patented prescription pharmaceuticalsOTC and complementary medicinesGeneric prescription pharmaceuticals
 
Industry Activities
Antibacterial, antibiotic and antitoxinVaccineVitamin productHerbal drugAmpoule, medicinal capsule, medicinal ointment and vialBiotechnological pharmaceutical and medicinal productsSerum and blood serumDiagnostic substance


View Sample
Quote
Select Clients